On October 25, 2022, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. amended the terms and closed the transaction. The company issued 49,921,506 A shares at an issue price of CNY 6.37 per share for aggregate gross proceeds of CNY 317,999,993.22. The transaction included participation from Shanghai Yanghe Investment Management Co., Ltd. for 47,095,761 shares and individual investor, Lin Hongyuan for 2,825,745 shares.

CNY 49,921,506.00 went towards paid-in share capital and CNY 258,322,239.55 towards capital reserve (share capital premium). The company incurred issuance fee of CNY 9,756,247.67 (excluding tax) and underwriting sponsorship fee of CNY 3,400,000.